This Is What Whales Are Betting On AbbVie
Portfolio Pulse from Benzinga Insights
Wealthy investors are showing a bullish stance on AbbVie (NYSE:ABBV) with significant options trades detected. The sentiment is 63% bullish and 36% bearish, with a price range target of $150 to $175. Analysts have mixed ratings but generally positive outlooks with target prices ranging from $180 to $200.
May 22, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wealthy investors are showing a bullish stance on AbbVie (NYSE:ABBV) with significant options trades detected. The sentiment is 63% bullish and 36% bearish, with a price range target of $150 to $175. Analysts have mixed ratings but generally positive outlooks with target prices ranging from $180 to $200.
The detection of significant options trades with a majority being bullish indicates strong investor confidence in AbbVie's short-term performance. Analysts' positive ratings further support this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100